Key result
High ERAS compliance is linked to ~57% less postoperative ileus but not fewer 30-day complications.
Why the study?
Radical cystectomy morbidity remains a serious challenge, with postoperative ileus being a common complication leading to longer length of stay, motivating assessment of ERAS protocol compliance impact.
Does high compliance to the ERAS protocol improve bowel recovery, complications, and length of stay in patients undergoing radical cystectomy for bladder cancer?
Cohort (n=108)
Does high compliance to the ERAS protocol improve bowel recovery, complications, and length of stay in patients undergoing radical cystectomy for bladder cancer?
Absolute Event Rate: 73% vs 86%
p-value: p=0.82
Higher compliance to the ERAS protocol in radical cystectomy patients facilitates faster bowel recovery and prevents postoperative ileus, though it may not significantly impact overall 30-day complications or length of stay.
ERAS compliance may hasten bowel recovery after RC; leaves open effects on complications and LOS pending higher-level evidence.
Background: Despite existing standardized surgical techniques and the development of new perioperative care protocols, radical cystectomy (RC) morbidity remains a serious challenge for urologists. Postoperative ileus (POI) is one of the most common postoperative complications, often leading to a longer length of stay (LOS). The aim of our study was to assess the impact of compliance to the Enhanced Recovery After Surgery (ERAS®) protocol on bowel recovery, 30-day complications and LOS after RC for bladder cancer (BC). Methods: Data from consecutive patients undergoing RC for BC within an ERAS® dedicated protocol were analyzed. Exclusion criteria were urinary diversion other than ileal conduit and palliative RC. Patients were divided into two groups according to their compliance (A: low-compliance and B: high-compliance). ERAS® compliance was extracted from the ERAS® Interactive Audit System (EIAS) database. Postoperative complications were prospectively recorded by a dedicated study nurse 30 days after RC. POI was defined as the placement of a nasogastric tube. Logistic regression analysis was used to identify predictors of 30-day complications and POI. Results: After considering the exclusion criteria, 108 patients were included for the final analysis. The median global compliance to the ERAS® protocol was 61%. A total of 78 (72%) patients had a compliance <65% (group A), while the remaining 30 (28%) had a compliance >65% (group B). No significant differences were found among the two groups regarding the 30-day complication rate (86% in group A versus 73% in group B, p = 0.82) and LOS (14 days in group A versus 15 days in group B, p = 0.82). The time to stool was significantly shorter in group B (4 days versus 6 days, p = 0.02), and the time to tolerate solid food was slightly faster in group B but not significant (8 versus 7 days, p = 0.23). The POI rate was significantly lower in patients with a higher ERAS® compliance (20% versus 46%, p = 0.01). A multivariate analysis showed that ERAS® compliance was not significantly associated with 30-day total complications. However, a lower compliance to the ERAS® protocol and age > 75 years were significant independent predictors of POI. Conclusions: Our study provides further evidence to support the beneficial effect of the ERAS® protocol in patients undergoing RC, particularly in terms of facilitating a faster recovery of bowel function and preventing POI. Future research should focus on investigating novel approaches and interventions to improve compliance with the ERAS® protocol. This may involve patient education, multidisciplinary teamwork, and continuous quality improvement initiatives.
No takes yet. Share an insight, caveat, or question.
Grilo et al. (2024) conducted a cohort in Bladder cancer (n=108). High compliance (>65%) to ERAS protocol vs. Low compliance (<65%) to ERAS protocol was evaluated on 30-day complication rate (p=0.82). High ERAS protocol compliance (>65%) after radical cystectomy did not reduce 30-day complications (73% vs 86%, p=0.82) but significantly lowered postoperative ileus rates (20% vs 46%, p=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: